CAD falls within cost-effectiveness range
Combining computer-aided detection with screening mammography increases marginal costs per year of life saved by 19%. This is well within the cost-effectiveness range of other medical procedures, according to a study presented Monday.
Combining computer-aided detection with screening mammography increases marginal costs per year of life saved by 19%. This is well within the cost-effectiveness range of other medical procedures, according to a study presented Monday.
An estimated 25% to 30% of all screening mammography exams performed in the U.S. are interpreted with the help of CAD, but to date no study has evaluated the cost-effectiveness its use, said Dr. Karen K. Lindfors, chief of breast imaging at the University of California, Davis.
Using a computer model based on published data, Lindfors and colleagues evaluated the impact of CAD costs by comparing three hypothetical groups of women aged 40 to 79: one undergoing screening mammography with CAD, one undergoing screening mammography without CAD, and a third undergoing observation without screening.
The computer model was based on cancer detection rates arising out of a prospective study of screening mammography and CAD published in 2001 by Dr. Timothy Freer.
In Freer's study, 12,860 screening mammograms were interpreted with the assistance of CAD over a one-year period. Cancer detection increased by 19.5%, and the proportion of early stage (0 and I) malignancies detected rose from 73% to 78% (Radiology 2001;220:781-786). Lindfors also based probability of outcomes on the Freer study.
Survival rates were modeled on five-year statistics generated by the American Cancer Society. Costs for screening mammography and CAD were based on 2003 average global Medicare reimbursements of $82.77 and $19.13, respectively.
Lindfors found that adding CAD to a mammography screening program results in a marginal cost per year of life saved (MCYLS) of $19,508.
The MCYLS to provide screening mammography without CAD compared with observation only is $16,023, she said.
"While the MCYLS that we found does fall within the accepted range for other medical procedures, a magnitude change in the cancer detection rate with CAD could dramatically increase its cost-effectiveness," Lindfors said.
Such data could be forthcoming, she said, citing research in press by Dr. Tommy E. Cupples of the South Carolina Comprehensive Breast Center that will report a MCYLS of $7933 when CAD is paired with screening mammography.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
